查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1603804

2030 年生物陶瓷市場預測：按類型、材料類型、形式、應用、最終用戶和地區進行的全球分析

Bioceramics Market Forecasts to 2030 - Global Analysis By Type (Bio-inert, Bio-active and Bio-resorbable), Material Type (Alumina, Zirconia, Hydroxyapatite (HAp) and Other Materials), Form, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球生物陶瓷市場規模將達82億美元，預計2030年將達到133億美元，預測期內複合年成長率為8.3%。

生物陶瓷是專為牙科和醫療應用而製造的陶瓷材料。由於其高生物相容性，在人體內使用是安全的。它們與活體組織良好相互作用的能力使其在組織工程、牙齒修復和整形外科植入中很受歡迎。生物陶瓷中使用的材料分為三類：惰性、生物活性和生物可吸收，通常包括羥磷石灰、氧化鋯、氧化鋁和磷酸鈣陶瓷。

根據美國整形外科) 的數據，2019 年大約進行了 125 萬例涉及髖關節和膝關節的 TJA 手術。

肌肉骨骼疾病增加

骨關節炎、骨質疏鬆症和牙齒問題等肌肉骨骼疾病的日益普及正在推動對生物陶瓷的需求。隨著世界人口老化，對整形外科植入、牙科修補和骨移植的需求不斷增加。生物陶瓷是這些應用的理想選擇，因為它們具有生物相容性並與天然骨組織整合。因此，退化性關節疾病和牙科疾病的負擔不斷增加，推動了市場的成長。

耐用性問題

儘管生物陶瓷具有許多優點，但與傳統金屬植入相比，其長期耐用性和機械強度仍然令人擔憂。陶瓷材料很脆，在高應力下容易斷裂。這限制了其在特定負載應用中的使用。一些外科醫生對於廣泛使用生物陶瓷猶豫不決，因為隨著時間的推移可能會出現植入失敗或失效的可能性。

醫療科技的進步

3D列印、奈米技術和組織工程等醫療技術的快速進步正在為生物陶瓷創造新的機會。 3D 列印可以創建具有複雜多孔結構的自訂形狀植入。奈米結構生物陶瓷表現出增強的生物和機械性能。使用生物陶瓷支架的組織工程方法有望用於骨骼和軟骨再生。這些技術進步正在擴大生物陶瓷材料在醫療設備中的潛在應用並提高其性能。

嚴格的監管要求

醫療設備業面臨嚴格的法律規範，尤其是生物陶瓷等植入材料。新生物陶瓷產品獲得監管部門的核准需要進行廣泛的測試和臨床試驗，這既耗時又昂貴。不同地區不斷變化的法規和標準增加了複雜性。嚴格的品管和文件要求增加了製造成本。漫長的核准流程和高監管壁壘威脅著生物陶瓷領域的市場成長和創新。

COVID-19 的影響：

COVID-19 大流行嚴重擾亂了 2020 年的生物陶瓷市場。選擇性手術和牙科治療被推遲，減少了對整形外科和牙科植入的需求。供應鏈中斷影響了原料的供應和生產。然而，隨著醫療保健活動正常化，市場已表現出彈性並正在復甦。此次疫情凸顯了感染控制的重要性，並可能增加人們對抗菌生物陶瓷的興趣。總體而言，雖然COVID-19造成了短期挫折，但預計不會對生物陶瓷市場的長期成長軌跡產生任何持久的負面影響。

惰性領域預計將在預測期內成為最大的領域

由於其卓越的機械性能和化學穩定性，預計惰性領域在預測期內將佔據最大的市場佔有率。這些材料廣泛用於承重整形外科植入，例如髖關節和膝關節假體。由於與身體組織的反應性低，適合長期植入。骨關節炎盛行率的增加和全關節重建手術數量的增加正在推動對惰性生物陶瓷的需求。其臨床記錄和完善的製造流程有助於其市場主導地位。

磷酸鈣陶瓷產業預計在預測期內複合年成長率最高。

預計磷酸鈣陶瓷產業在預測期內將以最高複合年成長率成長。這些材料與天然骨的礦物質含量非常相似，並具有出色的生物活性和骨整合能力。它擴大用於人工植牙、骨移植物和金屬植入的塗層。對再生醫學和組織工程的日益關注正在推動對磷酸鈣支架的研究。促進骨骼生長和重塑的磷酸鈣支架對各種整形外科和牙科應用具有吸引力，推動了市場的快速擴張。

比最大的地區

預計歐洲在預測期內將主導生物陶瓷市場佔有率。該地區龐大的老齡化人口和高昂的醫療保健支出正在推動對整形外科和牙科植入的需求。歐洲擁有大量專注於生物陶瓷技術創新的主要醫療設備製造商和研究機構。德國和法國等國家的植入治療優惠報銷政策正在支持市場成長。該地區先進的醫療保健基礎設施和較早採用新醫療技術有助於其在生物陶瓷市場的領導地位。

複合年成長率最高的地區：

預計北美將成為生物陶瓷市場成長率最高的地區。該地區在生物材料和再生醫學領域的積極研發活動正在推動生物陶瓷技術的創新。牙科和整形外科疾病盛行率的增加以及醫療保健意識的提高正在推動需求。主要市場參與者的存在以及新型生物陶瓷產品正在進行的臨床試驗正在促進市場的快速擴張。對先進醫療植入的投資增加以及向微創手術的轉變進一步加速了北美市場的成長。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球生物陶瓷市場：依類型

  • 惰性
  • 生物活性
  • 生物可吸收的

第6章全球生物陶瓷市場：依材料類型

  • 氧化鋁
  • 氧化鋯
  • 羥磷石灰(HAp)
  • 玻璃陶瓷
    • 生物活性玻璃
    • 玻璃增強陶瓷
  • 磷酸鈣陶瓷
    • 磷酸三鈣 (TCP)
    • 雙相磷酸鈣 (BCP)
  • 其他材料類型

第7章全球生物陶瓷市場：依形式

  • 粉末
  • 液體

第8章全球生物陶瓷市場：依應用分類

  • 整形外科
  • 牙科
  • 組織工程
  • 藥物輸送
  • 其他用途

第9章全球生物陶瓷市場：依最終用戶分類

  • 醫院
  • 診所
  • 調查機構
  • 其他最終用戶

第10章全球生物陶瓷市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • CoorsTek, Inc.
  • Kyocera Corporation
  • Morgan Advanced Materials Plc
  • CeramTec GmbH
  • Tosoh Ceramics Co., Ltd.
  • Institut Straumann AG
  • Berkeley Advanced Biomaterials
  • DSM
  • Stryker Corporation
  • Dentsply Sirona
  • Zimmer-Biomet Holdings
  • 3M Company
  • BONESUPPORT
  • DePuy Synthes
  • Amedica Corporation
  • Nobel Biocare Services AG
  • CAM Bioceramics
  • Collagen Matrix Inc.
Product Code: SMRC27826

According to Stratistics MRC, the Global Bioceramics Market is accounted for $8.2 billion in 2024 and is expected to reach $13.3 billion by 2030, growing at a CAGR of 8.3% during the forecast period. Bioceramics are ceramic materials created especially for dental and medical applications. They are safe to use inside the human body because of their biocompatibility. Their ability to interact well with biological tissues makes them popular in tissue engineering, dental restorations, and orthopedic implants. The materials used to make bioceramics, which fall into three categories-bioinert, bioactive, and bioresorbable-usually include hydroxyapatite, zirconia, alumina, and calcium phosphate ceramics.

According to the American Academy of Orthopaedic Surgeons (AAOS) in 2019, approximately 1.25 million TJA procedures, including hip and knee arthroplasties, were performed.

Market Dynamics:

Driver:

Rising incidence of musculoskeletal conditions

The increasing prevalence of musculoskeletal disorders like osteoarthritis, osteoporosis, and dental issues is driving demand for bioceramics. As the global population ages, there is growing need for orthopedic implants, dental prosthetics, and bone grafts. Bioceramics offer excellent biocompatibility and integration with natural bone tissue, making them ideal for such applications. The rising burden of degenerative joint diseases and dental problems is thus propelling market growth.

Restraint:

Durability concerns

While bioceramics offer many advantages, there are still some concerns about their long-term durability and mechanical strength compared to traditional metallic implants. Ceramic materials can be brittle and prone to fracture under high stress. This limits their use in certain load-bearing applications. The potential for implant failure or breakage over time makes some surgeons hesitant to use bioceramics extensively.

Opportunity:

Advancements in medical technology

Rapid progress in medical technologies like 3D printing, nanotechnology, and tissue engineering is creating new opportunities for bioceramics. 3D printing allows for the fabrication of custom-shaped implants with intricate porous structures. Nanostructured bioceramics exhibit enhanced biological and mechanical properties. Tissue engineering approaches using bioceramic scaffolds show promise for regenerating bone and cartilage. These technological advancements are expanding the potential applications and improving the performance of bioceramic materials in medical devices.

Threat:

Stringent regulatory requirements

The medical device industry faces rigorous regulatory oversight, particularly for implantable materials like bioceramics. Obtaining regulatory approvals for new bioceramic products involves extensive testing and clinical trials, which can be time-consuming and expensive. Changing regulations and standards across different regions add complexity. Stringent quality control and documentation requirements increase manufacturing costs. The lengthy approval process and high regulatory barriers pose a threat to market growth and innovation in the bioceramics sector.

Covid-19 Impact:

The COVID-19 pandemic significantly disrupted the bioceramics market in 2020. Elective surgeries and dental procedures were postponed, reducing demand for orthopedic and dental implants. Supply chain disruptions affected raw material availability and production. However, the market showed resilience and is recovering as healthcare activities normalize. The pandemic highlighted the importance of infection control, potentially boosting interest in antimicrobial bioceramics. Overall, while causing short-term setbacks, COVID-19 is not expected to have lasting negative impacts on the long-term growth trajectory of the bioceramics market.

The bio-inert segment is expected to be the largest during the forecast period

The bio-inert segment is projected to hold the largest market share over the forecasted timeframe due to their excellent mechanical properties and chemical stability. These materials are widely used in load-bearing orthopedic implants like hip and knee replacements. Their low reactivity with body tissues makes them suitable for long-term implantation. The growing prevalence of osteoarthritis and rising number of joint replacement surgeries are driving demand for bio-inert bioceramics. Their proven clinical track record and established manufacturing processes contribute to their market dominance.

The calcium phosphate ceramics segment is expected to have the highest CAGR during the forecast period

During the projection period, the calcium phosphate ceramics segment is expected to grow at the highest CAGR. These materials closely resemble the mineral component of natural bone, offering superior bioactivity and osseointegration. They are increasingly used in dental implants, bone grafts, and coatings for metallic implants. The rising focus on regenerative medicine and tissue engineering is boosting research into calcium phosphate scaffolds. Their ability to promote bone growth and remodeling makes them attractive for various orthopedic and dental applications, driving rapid market expansion.

Region with largest share:

Europe is expected to dominate the bioceramics market share during the forecast period. The region's large and aging population, coupled with high healthcare expenditure, drives demand for orthopedic and dental implants. Europe has a strong presence of leading medical device manufacturers and research institutions focusing on bioceramic innovations. Favorable reimbursement policies for implant procedures in countries like Germany and France support market growth. The region's advanced healthcare infrastructure and early adoption of new medical technologies contribute to its market leadership in bioceramics.

Region with highest CAGR:

North America is projected to exhibit the highest growth rate in the bioceramics market. The region's robust research and development activities in biomaterials and regenerative medicine are driving innovation in bioceramic technologies. The increasing prevalence of dental and orthopedic disorders, coupled with rising healthcare awareness, is boosting demand. The presence of key market players and ongoing clinical trials for novel bioceramic products contribute to rapid market expansion. Growing investments in advanced medical implants and the shift towards minimally invasive surgeries are further accelerating market growth in North America..

Key players in the market

Some of the key players in Bioceramics Market include CoorsTek, Inc., Kyocera Corporation, Morgan Advanced Materials Plc, CeramTec GmbH, Tosoh Ceramics Co., Ltd., Institut Straumann AG, Berkeley Advanced Biomaterials, DSM, Stryker Corporation, Dentsply Sirona, Zimmer-Biomet Holdings, 3M Company, BONESUPPORT, DePuy Synthes, Amedica Corporation, Nobel Biocare Services AG, CAM Bioceramics, and Collagen Matrix Inc.

Key Developments:

In October 2024, Straumann Group has increased its stake in Createch Medical and acquired shares in botiss biomaterials. These acquisitions enhance Straumann's capabilities in CAD/CAM prosthetic solutions and regenerative biomaterials for dental implantology.

In August 2024, Kyoto Sangyo University, Kyocera, and Photocross Collaborate on World-First Ground-Based Telescope Innovations. To realize a reflecting telescope equipped with a large, lightweight fine cordierite mirror, a world's first achievement, and to develop ceramic reflective optical systems for infrared astronomical observation instruments, Kyoto Sangyo University, Kyocera Corporation (hereafter "Kyocera"), and Photocross, Co., Ltd. (hereafter "Photocross") have reached a comprehensive and detailed agreement. This agreement outlines each party's roles and responsibilities, the project timeline, and the expected outcomes, ensuring a coordinated and effective collaboration.

In June 2024, CeramTec introduced Sinalit, a silicon nitride-based substrate at the PCIM Europe trade fair. This product expands their portfolio of high-performance ceramics for medical technology.

Types Covered:

  • Bio-inert
  • Bio-active
  • Bio-resorbable

Material Types Covered:

  • Alumina
  • Zirconia
  • Hydroxyapatite (HAp)
  • Glass Ceramics
  • Calcium Phosphate Ceramics
  • Other Material Types

Forms Covered:

  • Powder
  • Liquid

Applications Covered:

  • Orthopedics
  • Dentistry
  • Tissue Engineering
  • Drug Delivery
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioceramics Market, By Type

  • 5.1 Introduction
  • 5.2 Bio-inert
  • 5.3 Bio-active
  • 5.4 Bio-resorbable

6 Global Bioceramics Market, By Material Type

  • 6.1 Introduction
  • 6.2 Alumina
  • 6.3 Zirconia
  • 6.4 Hydroxyapatite (HAp)
  • 6.5 Glass Ceramics
    • 6.5.1 Bioactive Glass
    • 6.5.2 Glass-Reinforced Ceramics
  • 6.6 Calcium Phosphate Ceramics
    • 6.6.1 Tricalcium Phosphate (TCP)
    • 6.6.2 Biphasic Calcium Phosphate (BCP)
  • 6.7 Other Material Types

7 Global Bioceramics Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid

8 Global Bioceramics Market, By Application

  • 8.1 Introduction
  • 8.2 Orthopedics
  • 8.3 Dentistry
  • 8.4 Tissue Engineering
  • 8.5 Drug Delivery
  • 8.6 Other Applications

9 Global Bioceramics Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Research Institutes
  • 9.5 Other End Users

10 Global Bioceramics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 CoorsTek, Inc.
  • 12.2 Kyocera Corporation
  • 12.3 Morgan Advanced Materials Plc
  • 12.4 CeramTec GmbH
  • 12.5 Tosoh Ceramics Co., Ltd.
  • 12.6 Institut Straumann AG
  • 12.7 Berkeley Advanced Biomaterials
  • 12.8 DSM
  • 12.9 Stryker Corporation
  • 12.10 Dentsply Sirona
  • 12.11 Zimmer-Biomet Holdings
  • 12.12 3M Company
  • 12.13 BONESUPPORT
  • 12.14 DePuy Synthes
  • 12.15 Amedica Corporation
  • 12.16 Nobel Biocare Services AG
  • 12.17 CAM Bioceramics
  • 12.18 Collagen Matrix Inc.

List of Tables

  • Table 1 Global Bioceramics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Bioceramics Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Bioceramics Market Outlook, By Bio-inert (2022-2030) ($MN)
  • Table 4 Global Bioceramics Market Outlook, By Bio-active (2022-2030) ($MN)
  • Table 5 Global Bioceramics Market Outlook, By Bio-resorbable (2022-2030) ($MN)
  • Table 6 Global Bioceramics Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 7 Global Bioceramics Market Outlook, By Alumina (2022-2030) ($MN)
  • Table 8 Global Bioceramics Market Outlook, By Zirconia (2022-2030) ($MN)
  • Table 9 Global Bioceramics Market Outlook, By Hydroxyapatite (HAp) (2022-2030) ($MN)
  • Table 10 Global Bioceramics Market Outlook, By Glass Ceramics (2022-2030) ($MN)
  • Table 11 Global Bioceramics Market Outlook, By Bioactive Glass (2022-2030) ($MN)
  • Table 12 Global Bioceramics Market Outlook, By Glass-Reinforced Ceramics (2022-2030) ($MN)
  • Table 13 Global Bioceramics Market Outlook, By Calcium Phosphate Ceramics (2022-2030) ($MN)
  • Table 14 Global Bioceramics Market Outlook, By Tricalcium Phosphate (TCP) (2022-2030) ($MN)
  • Table 15 Global Bioceramics Market Outlook, By Biphasic Calcium Phosphate (BCP) (2022-2030) ($MN)
  • Table 16 Global Bioceramics Market Outlook, By Other Material Types (2022-2030) ($MN)
  • Table 17 Global Bioceramics Market Outlook, By Form (2022-2030) ($MN)
  • Table 18 Global Bioceramics Market Outlook, By Powder (2022-2030) ($MN)
  • Table 19 Global Bioceramics Market Outlook, By Liquid (2022-2030) ($MN)
  • Table 20 Global Bioceramics Market Outlook, By Application (2022-2030) ($MN)
  • Table 21 Global Bioceramics Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 22 Global Bioceramics Market Outlook, By Dentistry (2022-2030) ($MN)
  • Table 23 Global Bioceramics Market Outlook, By Tissue Engineering (2022-2030) ($MN)
  • Table 24 Global Bioceramics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 25 Global Bioceramics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 26 Global Bioceramics Market Outlook, By End User (2022-2030) ($MN)
  • Table 27 Global Bioceramics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 28 Global Bioceramics Market Outlook, By Clinics (2022-2030) ($MN)
  • Table 29 Global Bioceramics Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 30 Global Bioceramics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.